Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950168-99-000935
Filing Date
1999-03-30
Accepted
1999-03-30 00:00:00
Documents
1
Period of Report
1999-05-12

Document Format Files

Seq Description Document Type Size
1 PHARMACEUTICAL PRODUCT DEVELOPMENT,INC DEF 14A 166718
  Complete submission text file 0000950168-99-000935.txt   168094
Mailing Address
Business Address 3151 17TH ST EXTENSION WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-27570 | Film No.: 99576994
SIC: 8731 Services-Commercial Physical & Biological Research